Project AT-01

N/A

Report date: 2025/01/21 14:45:49

Base Information

Drug NameProject AT-01
Drug Alias NameProject AT-01 payloaded AxcynDOTAT-01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Inactive tyrosine-protein kinase transmembrane receptor ROR1
TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAxcynsis Therapeutics Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAxcynsis Therapeutics Pte Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A